Human Insulin Like Growth Factor Binding Protein 7 (IGFBP7) ELISA Kit

Quantitative measurement of human Insulin-like Growth Factor Binding Protein 7 supports active research areas including acute kidney injury biomarker discovery, cellular senescence mechanisms, and tumor microenvironment studies. This immunoassay from Assay Genie provides the reagents needed to detect endogenous IGFBP7 levels across multiple sample preparations, including plasma and serum samples, prepared tissue homogenates, cell lysates, and cell culture supernatants.

The kit is configured for 96 determinations in a standard microplate format, with components validated for in vitro research use. IGFBP7 has emerged as a clinically relevant biomarker, particularly in nephrology research where it has been studied alongside tissue inhibitor of metalloproteinases 2 (TIMP-2) for early detection of kidney stress. In oncology, altered IGFBP7 expression has been documented in clear cell renal carcinoma, breast cancer, and glioblastoma, supporting its investigation as a target in tumor biology.

Each kit provides pre-coated microplate wells, detection antibody reagents, protein reference standards, enzyme conjugate, substrate solution, and wash buffer required to generate standard curves and quantify target levels. The assay accommodates laboratory research applications including biomarker validation studies, investigation of growth factor signaling pathways, and disease mechanism research in academic and pharmaceutical settings.